Control on drug quality, safety and price restricted by the instruction of President : Suren Krmoyan

YEREVAN, OCTOBER 2, ARMENPRESS: Quality, safety and cost control in the drug market is in the center of attention of both the head of the country personally and the society. The instructions by the President of the Republic refer to the issue were clear and strict. Armenpress had an interview with the chief of the staff of Armenian Ministry of Health Suren Krmoyan.

''Market economy rules are prevailing in Armenia yet competitive field is needed for possessing normal prices. Armenian Ministry of Health and our partners are caring no efforts aimed at operating competitive conditions, as the field lacks norms, mechanisms which should regulate drug pricing system. Competitive conditions will enable to define certain market prices for the imported drugs, which will later on contribute to the import of large amount of drugs. Armenian Ministry of Health is elaborating a law which stipulates price defining of the drugs in great demand, which stands, that the drug acquires fixed price when in the border of Armenia. Armenian President gave an instruction on September 29 to regulate the issues pertain to the drugs, namely quality, safety, started from professional approach up to licensing of wholesale trade, besides elaboration of price reduction with the precondition of ensuring high quality, so the consumer must be sure he is paying for quality medicine'' the chief of the staff underscored.